Risultati della ricerca - Rohit Sukumar
- Mostra 1 - 5 risultati su 5
-
1
Preclinical Evaluation of Genexol-PM, a Nanoparticle Formulation of Paclitaxel, as a Novel Radiosensitizer for the Treatment of Non-Small Cell Lung Cancer di Michael E. Werner, Natalie D. Cummings, Manish Sethi, Edina C. Wang, Rohit Sukumar, Dominic T. Moore, Andrew Z. Wang
Pubblicazione 2013Artigo -
2
-
3
Polysilsesquioxane nanoparticles for triggered release of cisplatin and effective cancer chemoradiotherapy di Joseph Della Rocca, Michael E. Werner, Stephanie Krämer, Rachel C. Huxford‐Phillips, Rohit Sukumar, Natalie D. Cummings, Juan L. Vivero‐Escoto, Andrew Z. Wang, Wenbin Lin
Pubblicazione 2014Artigo -
4
Folate-Targeted Polymeric Nanoparticle Formulation of Docetaxel Is an Effective Molecularly Targeted Radiosensitizer with Efficacy Dependent on the Timing of Radiotherapy di Michael E. Werner, Jonathan A. Copp, Shrirang Karve, Natalie D. Cummings, Rohit Sukumar, Chenxi Li, Mary E. Napier, Ronald C. Chen, Adrienne D. Cox, Andrew Z. Wang
Pubblicazione 2011Artigo -
5
Strumenti per la ricerca:
Soggetti correlati
Biology
Biotechnology
Cancer research
In vivo
Internal medicine
Medicine
Radiation therapy
Chemotherapy
Pharmacology
Oncology
Radiosensitizer
Biochemistry
Cancer
Cancer cell
Chemistry
Chemoradiotherapy
Cisplatin
Folate receptor
Lung cancer
Materials science
Nanoparticle
Nanotechnology
Paclitaxel
Biophysics
Docetaxel
Drug
Drug delivery
In vitro
Kinase
Metastasis